Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis
Several studies demonstrated the efficacy of the B-cell depletion therapy with rituximab (RTX) in RA patients, including those unresponsive to anti- TNF therapy, underlying the important role of B cells in this disease (1-5). Several recent papers have demonstrated a differential effects of RTX in d...
Main Authors: | , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2011-06-01
|
Series: | Reumatismo |
Online Access: | http://www.reumatismo.org/index.php/reuma/article/view/490 |
_version_ | 1828365845757165568 |
---|---|
author | F. Fischetti L.M. Bambara A. Carletto M. Cutolo P. Sarzi-Puttini R. Pellerito C. Fabro E. Pontarini M.A. Cimmino P. Morassi F. Atzeni M. Saracco M. Manfredi M. Benucci S. Lombardi L. Quartuccio M. Fabris F. Curcio E. Tonutti S. De VIta |
author_facet | F. Fischetti L.M. Bambara A. Carletto M. Cutolo P. Sarzi-Puttini R. Pellerito C. Fabro E. Pontarini M.A. Cimmino P. Morassi F. Atzeni M. Saracco M. Manfredi M. Benucci S. Lombardi L. Quartuccio M. Fabris F. Curcio E. Tonutti S. De VIta |
author_sort | F. Fischetti |
collection | DOAJ |
description | Several studies demonstrated the efficacy of the B-cell depletion therapy with rituximab (RTX) in RA patients, including those unresponsive to anti- TNF therapy, underlying the important role of B cells in this disease (1-5). Several recent papers have demonstrated a differential effects of RTX in depleting B-cells and blocking plasma cell generation at the synovial and at the bone marrow level (7-9). This differential effect may explain why among patients who respond to RTX, some relapse while others show a very prolonged response, independently from the reappearance of B-cells in the peripheral blood (6). However, the efficacy of RTX may also depend on the individual genetic predisposition. At this regard, very few data were produced by now. |
first_indexed | 2024-04-14T05:37:13Z |
format | Article |
id | doaj.art-22935c537dcc40a9b1adadb7989db87f |
institution | Directory Open Access Journal |
issn | 0048-7449 2240-2683 |
language | English |
last_indexed | 2024-04-14T05:37:13Z |
publishDate | 2011-06-01 |
publisher | PAGEPress Publications |
record_format | Article |
series | Reumatismo |
spelling | doaj.art-22935c537dcc40a9b1adadb7989db87f2022-12-22T02:09:35ZengPAGEPress PublicationsReumatismo0048-74492240-26832011-06-0162425325810.4081/reumatismo.2010.253Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritisF. FischettiL.M. BambaraA. CarlettoM. CutoloP. Sarzi-PuttiniR. PelleritoC. FabroE. PontariniM.A. CimminoP. MorassiF. AtzeniM. SaraccoM. ManfrediM. BenucciS. LombardiL. QuartuccioM. FabrisF. CurcioE. TonuttiS. De VItaSeveral studies demonstrated the efficacy of the B-cell depletion therapy with rituximab (RTX) in RA patients, including those unresponsive to anti- TNF therapy, underlying the important role of B cells in this disease (1-5). Several recent papers have demonstrated a differential effects of RTX in depleting B-cells and blocking plasma cell generation at the synovial and at the bone marrow level (7-9). This differential effect may explain why among patients who respond to RTX, some relapse while others show a very prolonged response, independently from the reappearance of B-cells in the peripheral blood (6). However, the efficacy of RTX may also depend on the individual genetic predisposition. At this regard, very few data were produced by now.http://www.reumatismo.org/index.php/reuma/article/view/490 |
spellingShingle | F. Fischetti L.M. Bambara A. Carletto M. Cutolo P. Sarzi-Puttini R. Pellerito C. Fabro E. Pontarini M.A. Cimmino P. Morassi F. Atzeni M. Saracco M. Manfredi M. Benucci S. Lombardi L. Quartuccio M. Fabris F. Curcio E. Tonutti S. De VIta Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis Reumatismo |
title | Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis |
title_full | Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis |
title_fullStr | Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis |
title_full_unstemmed | Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis |
title_short | Study on the possible role of the -174G>C IL-6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis |
title_sort | study on the possible role of the 174g c il 6 promoter polymorphism in predicting response to rituximab in rheumatoid arthritis |
url | http://www.reumatismo.org/index.php/reuma/article/view/490 |
work_keys_str_mv | AT ffischetti studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis AT lmbambara studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis AT acarletto studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis AT mcutolo studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis AT psarziputtini studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis AT rpellerito studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis AT cfabro studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis AT epontarini studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis AT macimmino studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis AT pmorassi studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis AT fatzeni studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis AT msaracco studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis AT mmanfredi studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis AT mbenucci studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis AT slombardi studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis AT lquartuccio studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis AT mfabris studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis AT fcurcio studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis AT etonutti studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis AT sdevita studyonthepossibleroleofthe174gcil6promoterpolymorphisminpredictingresponsetorituximabinrheumatoidarthritis |